Group 1 - The company has signed a maximum guarantee contract with Beijing Bank Xi'an Branch, providing a joint liability guarantee of 100 million yuan for its wholly-owned subsidiary Yangling Buchang Pharmaceutical Co., Ltd. [1][5] - The company and its subsidiaries have approved a total financing limit of up to 6.92 billion yuan for 2025, with a guarantee limit not exceeding 6.92 billion yuan, including a new guarantee limit of 2.6 billion yuan for the company itself [2][4] - The total amount of guarantees provided by the company and its subsidiaries is 2.5403079 billion yuan, accounting for 24.86% of the company's audited net assets as of the end of 2024, with no overdue guarantees reported [12] Group 2 - The guarantee is necessary for Yangling Buchang to meet its daily operational needs and is expected to positively impact the company's development and efficiency [10] - The board of directors believes that the subsidiary is stable and capable of fulfilling its obligations, and the guarantee does not harm the interests of the company or its shareholders [11] - The guarantee period is three years from the maturity of the guaranteed debt, covering all debts under the main contract, including principal, interest, penalties, and other related costs [8]
证券代码:603858 证券简称:步长制药 公告编号:2025-163